Due diligence and institutional cooperation in cross-border health projects
Why due diligence in cross-border health investment is more than a documentary checklist, especially in complex or fragile environments.
This page summarises the original article. Read the complete piece on LinkedIn.
In health projects involving cross-border financial transactions, due diligence is often treated as paperwork: verifying a licence, confirming that a company exists, identifying beneficial owners, validating regulatory authorisations and checking an investor’s financial capacity.
The argument in brief
- In environments affected by geopolitical, security or institutional instability, documentary checks alone are not enough.
- Cooperation between institutions, including regulators, financial authorities and health bodies, is what makes verification reliable.
- Due diligence is part of health security: it protects patients, public funds and legitimate investors from projects that cannot deliver.
Why it matters for clients
For investors and public partners entering new markets, the piece argues for treating integrity and verification as core project risks, assessed early, rather than as compliance formalities at the end.